The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

Officers raided an address in the Llanrwst area following reports that prescription weight-loss drugs were being sold without ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

Novo Nordisk finds itself navigating significant operational and market headwinds. The company is intensely focused on maintaining its leadership in the obes ...

One of the reasons for the internal disagreement at the club was the fact that the nutritionist Eduardo Rauen, who has been ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six ...

Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...